Category 'Market Reports'

  1. Which are the key antibody companies to watch?

    Last week we released our annual update on the global antibody supplier market, outlining those companies that have recently entered or neared the top ten, and have grown their share of the global market by over one per cent in the last year. Today we address another interesting part of this dataset – the companies […]

  2. Which antibody suppliers are challenging the big players?

    Today we’re releasing our updated antibody supplier market share dataset, ranking suppliers based on their global citation share. In the full dataset we cover market share for all suppliers, however on our blog today we are focusing on companies that have managed to grow from fairly lowly positions in the ranking, and capture more than […]

  3. Discover the most used anti-chemical antibodies

    Our new data released today focuses on the top anti-chemical antibodies and their targets. The majority of antibodies are raised against proteins – but some are raised against other molecules, which we term anti-chemical antibodies. CiteAb Product Manager Rhys Williams said: “To produce this dataset we looked at 2700 citations for antibodies raised against chemicals, […]

  4. Revealed: The top 100 cited antibodies of 2016

    New data from CiteAb reveals that just nine companies supply the top 100 antibodies cited over the whole of 2016. In addition, one single company is responsible for the supply of 38 of these antibodies. Dr Andrew Chalmers, founder of CiteAb, said: “This data comes from a set that shows trends in citation rates for […]

  5. New data – top custom antibody targets

    Following our blog last week about our new custom antibody dataset, today we’re going to look at this data in a little more detail, focusing on the top targets for custom antibodies. Our custom antibody data helps suppliers identify antibodies to license in, but also gives us a great insight to trends in the market. […]

  6. Who is the most popular custom antibody supplier?

    In a first for CiteAb, today we’re taking a first look at the global custom antibody market and we’ll be highlighting those suppliers claiming the largest share. CiteAb founder Dr Andrew Chalmers said: “As you know, we specialise in collating citations for catalogue antibodies, however over the last few months our team has been taking […]

  7. Top antibodies used to understand prostate cancer

    Last week we reported on our brand new text mining technology developed by our team here at CiteAb. Today we’re looking at some very specific data we can access as a result of this new technology – insights into the antibodies used in prostate cancer research. CiteAb developer Matt Helsby said: “Using this new text […]

  8. Chinese antibody market powers ahead

    Today we return to our first ever data report, released three years ago, when we claimed that China was a market no supplier could ignore, and we look at new data to see whether our predictions came true. Back in 2014 we stated that ‘the data suggests that China is set to claim the lion’s […]

  9. First look at the global chemical probes market

      We recently announced that our team here at CiteAb has expanded our platform to cover multiple reagent types, and today we’re taking a first look at some of our new data. The inhibitors and activators used by life scientists to investigate cellular processes are collectively termed as ‘chemical probes’. They provide vital tools for […]

  10. What are the most important antibody targets for immunocytochemistry?

    New to our series of blogs on antibody research applications, today we are exploring the top targets for ICC, or immunocytochemistry. ICC is the staining and microscopic examination of cells, which are often grown in culture. This is not to be confused with immunohistochemistry (IHC), which involves the staining of tissues with their normal organisation […]